wegovy or tirzepatide Zepbound beats for weight loss in first head-to-head trial of blockbuster drugs – WBOY.com Learn more about GLP 1

Muscle is essential for: Losing too much muscle can make it harder to maintain results once medication is reduced or stopped

Zepbound patients maintained ~80% Better absorption: Non-peptide formulation means easier absorption without dietary limitations Market Impact: While Novo Nordisk recently launched oral Wegovy as the first oral GLP-1 approved for weight loss, Lilly's orforglipron could offer competitive advantages with its flexible dosing and absorption profile

Yuma T, Tokuda M, Nishimoto N, Yokoi H, Izumori K

Subcutaneous semaglutide was administered, as per guidelines, with a progressive weekly increase for a total of 12 weeks

Our design caters to a range of medical professionals, such as med spas, weight loss clinics, functional medicine providers, and wellness clinics, who currently offer or plan to add tirzepatide to their practice